Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
25,973,289
-
Total 13F shares
-
3,271,748
-
Share change
-
+3,263,636
-
Total reported value
-
$88,277,281
-
Price per share
-
$27.01
-
Number of holders
-
59
-
Value change
-
+$88,060,120
-
Number of buys
-
52
-
Number of sells
-
4
Institutional Holders of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) as of Q2 2024
As of 30 Jun 2024,
Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,271,748 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., JPMORGAN CHASE & CO, Artal Group S.A., MPM BIOIMPACT LLC, Ikarian Capital, LLC, VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and Erste Asset Management GmbH.
This page lists
58
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.